Cost of Revenue of Cannabis Bioscience International Holdings, Inc. from 30 Nov 2022 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Cannabis Bioscience International Holdings, Inc. quarterly and annual Cost of Revenue in USD history and change rate from 30 Nov 2022 to 30 Nov 2025.
  • Cannabis Bioscience International Holdings, Inc. Cost of Revenue for the quarter ending 30 Nov 2025 was $10,500, a 35% increase year-over-year.
  • Cannabis Bioscience International Holdings, Inc. Cost of Revenue for the twelve months ending 30 Nov 2025 was $42,584, a 13% increase year-over-year.
  • Cannabis Bioscience International Holdings, Inc. annual Cost of Revenue for 2024 was $40,106, a 12% decline from 2023.
  • Cannabis Bioscience International Holdings, Inc. annual Cost of Revenue for 2023 was $45,599, a 51% decline from 2022.
Source SEC data
View on sec.gov
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

Cannabis Bioscience International Holdings, Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $42,584 $10,500 +$2,697 +35% 01 Sep 2025 30 Nov 2025 10-Q 19 Feb 2026 2026 Q2
Q3 2025 $39,887 $8,143 -$219 -2.6% 01 Jun 2025 31 Aug 2025 10-Q 22 Oct 2025 2026 Q1
Q2 2025 $40,106 $4,545 -$5,333 -54% 01 Mar 2025 31 May 2025 10-K 22 Sep 2025 2025 FY
Q1 2025 $45,439 $19,396 +$7,587 +64% 01 Dec 2024 28 Feb 2025 10-Q/A 09 May 2025 2025 Q3
Q4 2024 $37,852 $7,803 -$7,289 -48% 01 Sep 2024 30 Nov 2024 10-Q 19 Feb 2026 2026 Q2
Q3 2024 $45,141 $8,362 -$458 -5.2% 01 Jun 2024 31 Aug 2024 10-Q 22 Oct 2025 2026 Q1
Q2 2024 $45,599 $9,878 01 Mar 2024 31 May 2024 10-K 22 Sep 2025 2025 FY
Q1 2024 $11,809 -$12,311 -51% 01 Dec 2023 29 Feb 2024 10-Q/A 09 May 2025 2025 Q3
Q4 2023 $15,092 +$8,002 +113% 01 Sep 2023 30 Nov 2023 10-Q 25 Jan 2024 2024 Q2
Q3 2023 $8,820 01 Jun 2023 31 Aug 2023 10-Q 21 Oct 2024 2025 Q1
Q1 2023 $24,120 01 Dec 2022 28 Feb 2023 10-Q 22 Apr 2024 2024 Q3
Q4 2022 $7,090 01 Sep 2022 30 Nov 2022 10-Q 25 Jan 2024 2024 Q2

Cannabis Bioscience International Holdings, Inc. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $40,106 -$5,493 -12% 01 Jun 2024 31 May 2025 10-K 22 Sep 2025 2025 FY
2023 $45,599 -$47,851 -51% 01 Jun 2023 31 May 2024 10-K 22 Sep 2025 2025 FY
2022 $93,450 01 Jun 2022 31 May 2023 10-K 16 Sep 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.